Laboratory Corporation of America Holdings LH:NYSE (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 98.67 | 0.66 0.67% | 416,960 | 701.3K |
Latest News Headlines for Laboratory Corporation of America Holdings
BURLINGTON, N.C.--(BUSINESS WIRE)--October 15, 2014-- Laboratory Corporation of America(R) Holdings (LabCorp(R) ) (NYSE: LH) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the acquisition of LipoScience, Inc. (NASDAQ: LPDX) by LabCorp.
LabCorp's Acquisition of LipoScience Clears Antitrust Approval RALEIGH, N.C., Oct. 15, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the acquisition of LipoScience by Laboratory Corporation of America(R) Holdings (LabCorp(R) ) (NYSE:LH).
Latest Annual and Quarterly SEC Filings
More FilingsCompany Background
Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 98.62 |
| Previous Close | 98.01 |
| Day High | 99.35 |
| Day Low | 98.26 |
| 52 Week High | 9/9/2014 | 108.77 |
| 52 Week Low | 12/11/2013 | 87.01 |
| % Off 52 Week High | -9.29% |
| % Off 52 Week Low | 13.40% |
| Beta (5 Yr) | 0.68 |
| Volatility Avg | 10/17/2014 | 19.20 |
| 10-Day Avg. Volume | 701,327 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | 6.01 |
|---|---|
| P/E Ratio | 6/30/2014 | 16.4 |
| Market Cap | Mid Cap | 8.4B |
| Shares Outstanding | 84.90M |
| Float | 84.6M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | -- |
|---|---|
| Ex-Date | -- |
| Dividend Announcement | -- |
| Date of Record | -- |
| Payable | -- - -- |
| Payable Date | -- |
Peers Information HelpLH Laboratory Corporation of America Holdings vs. Peers
| Peers | |
|---|---|
LH Laboratory Corporation of America Holdings | 7.99% |
Quest Diagnostics Inc | 9.84% |
Psychemedics Corp. | -4.63% |
Bio-Reference Laboratories Inc | 10.57% |
Covance Inc. | -12.00% |
LH Laboratory Corporation of America Holdings | 0.00% |
Quest Diagnostics Inc | 2.24% |
Psychemedics Corp. | 4.28% |
Bio-Reference Laboratories Inc | -- |
Covance Inc. | -- |
LH Laboratory Corporation of America Holdings | 0.67% |
Quest Diagnostics Inc | 1.52% |
Psychemedics Corp. | 0.07% |
Bio-Reference Laboratories Inc | -0.70% |
Covance Inc. | 1.00% |